Pharmaceutical Corpn I M Kerala Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 46.28 Cr
- Company Age 49 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.02 Cr
- Revenue Growth 21.73%
- Profit Growth 182.12%
- Ebitda 163.83%
- Net Worth 22.73%
- Total Assets 23.46%
About Pharmaceutical Corpn I M Kerala
Pharmaceutical Corpn I M Kerala Ltd (PCIMKL) is a leading Private Limited State Government Company incorporated in India on 08 September 1975 and has a history of 49 years and five months. Its registered office is in Na, Kerala.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 46.28 Cr.
The company currently has active open charges totaling ₹1.02 Cr.
The Key Managerial Personnel (KMP) at Pharmaceutical Corpn I M Kerala Ltd India are Vinitha Sankaran as COMPANY SECRETARY and Lathakumari Madhavan as Cfo. Preetha Nair, Preeya Suseela, Padmanabhan Kolangarayath, and Six other members serve as directors at the Company.
Company Details
- Location Na, Kerala
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231KL1975SGC002722
- Company No.
002722
- Company Classification
Private Limited State Government Company
- Incorporation Date
08 Sep 1975
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Pharmaceutical Corpn I M Kerala?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Thoduvayil Hrideek ![]() | Managing Director | 14-Feb-2022 | Current |
Vinitha Sankaran | Company Secretary | 03-Sep-2010 | Current |
Lathakumari Madhavan | CFO | 09-Oct-2015 | Current |
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Preetha Nair ![]() | Director | 11-Mar-2019 | Current |
Preeya Suseela ![]() | Director | 26-Jun-2019 | Current |
Padmanabhan Kolangarayath ![]() | Nominee Director | 03-Oct-2022 | Current |
George Sobhana ![]() | Director | 15-Nov-2021 | Current |
Plaparambil Kuriakose ![]() | Nominee Director | 03-Oct-2022 | Current |
Kakkassery Davis ![]() | Nominee Director | 03-Oct-2022 | Current |
Financial Performance of Pharmaceutical Corpn I M Kerala.
Pharmaceutical Corpn I M Kerala Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 21.73% increase. The company also saw a substantial improvement in profitability, with a 182.12% increase in profit. The company's net worth Soared by an impressive increase of 22.73%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaceutical Corpn I M Kerala?
In 2023, Pharmaceutical Corpn I M Kerala had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹1.02 Cr
₹0
Charges Breakdown by Lending Institutions
- Kerala Financial Corporation : 0.52 Cr
- The Nedungadi Bank Limited : 0.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Jun 2001 | The Nedungadi Bank Limited | ₹5.00 M | Open |
02 Aug 1989 | Kerala Financial Corporation | ₹5.20 M | Open |
How Many Employees Work at Pharmaceutical Corpn I M Kerala?
Unlock and access historical data on people associated with Pharmaceutical Corpn I M Kerala, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Pharmaceutical Corpn I M Kerala, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaceutical Corpn I M Kerala's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.